+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Liver Cancer"

From
From
From
Interventional Oncology Global Market - Forecast to 2026 - Product Thumbnail Image

Interventional Oncology Global Market - Forecast to 2026

  • Report
  • September 2022
  • 377 Pages
  • Global
From
Global Interventional Oncology Market 2021-2026 - Product Thumbnail Image

Global Interventional Oncology Market 2021-2026

  • Report
  • December 2021
  • 108 Pages
  • Global
From
From
From
2019 Post European Society for Medical Oncology (ESMO) Report - Product Thumbnail Image

2019 Post European Society for Medical Oncology (ESMO) Report

  • Report
  • October 2019
  • 117 Pages
  • Europe
Loading Indicator

Liver cancer is a type of cancer that originates in the liver, an organ located in the upper right side of the abdomen. It is the fifth most common cancer worldwide and the third leading cause of cancer-related death. Symptoms of liver cancer can include abdominal pain, jaundice, and weight loss. Treatment options for liver cancer include surgery, chemotherapy, radiation therapy, and targeted therapy. The oncology market for liver cancer is highly competitive, with a range of treatments available. Pharmaceutical companies are investing in research and development to develop new treatments and improve existing ones. Additionally, the market is seeing an increase in the number of clinical trials for new treatments. Companies in the liver cancer market include AbbVie, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Merck, Novartis, Pfizer, and Roche. Show Less Read more